1978
DOI: 10.1001/archderm.114.9.1348
|View full text |Cite
|
Sign up to set email alerts
|

Pityriasis rubra pilaris responding to aminonicotinamide

Abstract: A 32-year-old man with pityriasis rubra pilaris diagnosed by clinical appearance and histologic examination was treated with 1% aminonicotinamide cream applied once daily. Improvement was noted within four days, and almost complete clearing occurred after two weeks of therapy. No side-effects were noted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

1980
1980
2003
2003

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…Van de Kerkhof and Steijlen 146 found that three patients showed substantial improvement with topical calcipotriol ointment, after 4 weeks of twice daily treatment. Other agents used to treat PRP include a combination of isoniazid and aminosalicylic acid, either with 147 or without 148 penicillin V, and topical 1% aminonicotinamide ,a potent antagonist of nicotinamide 149 , 150 . Hydroxychloroquine, 400 mg/day, was considered to be of doubtful efficacy 147 .…”
Section: Treatmentmentioning
confidence: 99%
“…Van de Kerkhof and Steijlen 146 found that three patients showed substantial improvement with topical calcipotriol ointment, after 4 weeks of twice daily treatment. Other agents used to treat PRP include a combination of isoniazid and aminosalicylic acid, either with 147 or without 148 penicillin V, and topical 1% aminonicotinamide ,a potent antagonist of nicotinamide 149 , 150 . Hydroxychloroquine, 400 mg/day, was considered to be of doubtful efficacy 147 .…”
Section: Treatmentmentioning
confidence: 99%
“…Andere,weniger häufig angewandte Substanzen umfassen Glukokortikosteroide [3], Azathioprin [23], Cyclosporin [3,40] sowie Calcipotriol für externe Anwendung [7,33,36,40,50]. Zu berücksichtigen ist,…”
Section: Weniger Häufig Angewandte Substanzenunclassified